Ono Pharmaceutical: Extraordinary Report
Ono Pharmaceutical: Confirmation letter
Ono Pharmaceutical: Securities Report - 76th Fiscal Year (April 1, 2023 - March 31, 2024)
Ono Pharmaceutical: Extraordinary Report
Ono Pharmaceutical: Extraordinary Report
Ono Pharmaceutical: Notice regarding differences between individual results and previous fiscal year results
Ono Pharmaceutical: Supplemental Financial Results for the Fiscal Year Ending March 31, 2012 (Consolidated IFRS)
Ono Pharmaceutical: Summary of financial results for the fiscal year ending 2024/3 [IFRS] (consolidated)
Ono Pharmaceutical: Confirmation letter
Ono Pharmaceutical: Quarterly Report - Third quarter of the 76th term (2023/10/01 to 2023/12/31)
Ono Pharmaceutical: Summary of financial results for the 3rd quarter of the fiscal year ending 2024/3 [IFRS] (consolidated)
Ono Pharmaceutical: Extraordinary Report
Ono Pharmaceutical: Confirmation letter
Ono Pharmaceutical: Quarterly Report - 76th Second Quarter (2023/07/01 - 2023/09/30)
Ono Pharmaceutical: Financial results supplementary materials for the 2nd quarter cumulative period ending March 2024 (April to September) (consolidated IFRS)
Ono Pharmaceutical: Brief financial results for the 2nd quarter of the fiscal year ending March 31, 2024 (consolidated, IFRS)
Ono Pharmaceutical: Quarterly Report - First Quarter 76 (2023/04/01 - 2023/06/30)
Ono Pharmaceutical: Confirmation letter
Ono Pharmaceutical: Summary of financial results for the first quarter of the fiscal year ending March 31, 2024 (consolidated IFRS)
Ono Pharmaceutical: Extraordinary Report
No Data